Form 4: Synlogic Head of Finance, Mary Beth Dooley, Sells Shares to Cover Tax Obligations

Mary Beth Dooley, Head of Finance at Synlogic, Inc., sold 79 shares of common stock on October 29, 2024, to cover tax liabilities related to a restricted stock award.

Summary

• On October 29, 2024, Mary Beth Dooley, Head of Finance at Synlogic, Inc., sold 79 shares of common stock.
• The sale was executed at a price of $1.4 per share.
• The transaction was to cover the tax liability associated with the vesting of a restricted stock award.
• The restricted stock award vested on October 28, 2024, and was initially granted on October 28, 2022.
• Following the transaction, Dooley directly owns 15,152 shares of Synlogic, Inc.

Sentiment

Score: 5

Explanation: This is a neutral transaction related to tax obligations, with no inherent positive or negative implications for the company's performance.

Industry Context

This is a routine Form 4 filing related to an executive's stock transactions, which is common in publicly traded companies. It doesn't necessarily indicate a broader trend within the biotechnology industry but reflects individual financial planning.

Comparison to Industry Standards

• Form 4 filings are standard practice for corporate insiders in publicly traded companies across all industries, including biotechnology.
• The sale of shares to cover tax liabilities upon vesting of restricted stock units is a common financial planning strategy among executives.
• Comparable companies such as Amgen, Biogen, and Gilead Sciences also have executives who regularly file Form 4s for similar transactions.

Stakeholder Impact

• The transaction has minimal impact on stakeholders as it is a routine sale of shares by an executive to cover tax liabilities.

Key Dates